| Name | Title | Contact Details |
|---|
Versant Health, a wholly-owned subsidiary of MetLife, is one of the nation`s leading managed vision care companies serving more than 37 million members nationwide. Through our Davis Vision plans and Superior Vision plans, we help members enjoy the wonders of sight through healthy eyes and vision. Providing vision and eye health solutions that range from routine vision benefits to medical management, Versant Health has a unique visibility and scale across the total eye health value chain. As a result, members enjoy a seamless experience with access to one of the broadest provider networks in the industry and an exclusive frame collection. Commercial groups, individuals, third parties and health plans that serve government-sponsored programs such as Medicaid and Medicare are among our valued customers.
Bold Air Respiratory Inc is a Brick, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Midmark Corporation makes medical, dental, and veterinary products and provides related services. It was founded in 1915 as The Cummings Machine Company.
Medical Home Network (MHN) is a formal provider collaborative working to improve the health of Medicaid recipients in Chicago by enhancing care coordination and quality, improving access and reducing fragmentation and cost, all while reinforcing the me...
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.